Decoy Therapeutics Income Statement (2014-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Revenue & cost
Revenue (Quarter)																				0.23M
Cost of Revenue (Quarter)
Gross Profit (Quarter)
Operating items
Research & Development (Quarter)	2.02M	2.70M	4.44M	2.92M	3.79M	4.69M	3.73M	2.35M	1.04M	0.06M	0.24M	0.21M	0.14M	-0.59M	0.08M	0.12M	0.06M	0.11M	0.75M	1.30M
Selling, General & Administrative (Quarter)	1.73M	1.45M	1.68M	1.84M	1.83M	1.79M	1.70M	1.62M	1.50M	0.91M	1.53M	1.25M	0.87M	1.31M	1.64M	0.85M	0.83M	0.40M	1.53M	1.33M
Other Operating Expenses (Quarter)					8.87M									0.77M				8.52M
Operating Expenses (Quarter)	3.75M	4.14M	6.12M	4.76M	14.49M	6.48M	5.42M	3.97M	2.53M	0.97M	1.77M	1.47M	1.01M	1.49M	1.72M	0.97M	0.90M	9.03M	2.28M	2.63M
Operating Income (Quarter)	-3.75M	-4.14M	-6.12M	-4.76M	-14.49M	-6.48M	-5.42M	-3.97M	-2.53M	-0.97M	-1.77M	-1.47M	-1.01M	-1.49M	-1.72M	-0.97M	-0.90M	-9.03M	-2.28M	-2.63M
EBIT (Quarter)	-3.75M	-4.14M	-6.12M	-4.76M	-14.49M	-6.48M	-5.42M	-3.97M	-2.53M	-0.97M	-1.77M	-1.47M	-1.01M	-1.49M	-1.72M	-0.97M	-0.90M	-9.03M	-2.28M	-2.63M
Non-operating items
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)	487.00		0.01M	0.04M	0.08M	0.09M	0.08M	0.09M	0.09M	0.09M	0.06M	0.04M	0.03M	0.02M	0.01M	0.01M	0.02M	0.06M	0.06M	0.03M
Net income details
EBT (Quarter)	-4.02M	-4.14M	-6.12M	-4.76M	-14.49M	-19.52M	-5.42M	-3.97M	-2.53M	-0.98M	-1.78M	-1.47M	-1.01M	-1.49M	-1.72M	-0.97M	-0.90M	-9.03M	-2.29M	-2.62M
Profit After Tax (Quarter)	-3.74M	-4.10M	-6.11M	-4.72M	-14.41M	-6.37M	-5.34M	-3.88M	-2.44M	-0.88M	-1.72M	-1.42M	-0.97M	-1.46M	-1.71M	-0.96M	-0.87M	-8.98M	-2.22M	-2.37M
Income from Continuing Operations (Quarter)	-4.02M	-4.14M	-6.12M	-4.76M	-14.49M	-19.52M	-5.42M	-3.97M	-2.53M	-0.98M	-1.78M	-1.47M	-1.01M	-1.49M	-1.72M	-0.97M	-0.90M	-9.03M	-2.29M	-2.62M
Consolidated Net Income (Quarter)	-4.02M	-4.14M	-6.12M	-4.76M	-14.49M	-19.52M	-5.42M	-3.97M	-2.53M	-0.98M	-1.78M	-1.47M	-1.01M	-1.49M	-1.72M	-0.97M	-0.90M	-9.03M	-2.29M	-2.62M
Income towards Parent Company (Quarter)	-4.02M	-4.14M	-6.12M	-4.76M	-14.49M	-19.52M	-5.42M	-3.97M	-2.53M	-0.98M	-1.78M	-1.47M	-1.01M	-1.49M	-1.72M	-0.97M	-0.90M	-9.03M	-2.29M	-2.62M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-4.02M	-4.14M	-6.12M	-4.76M	-14.49M	-19.52M	-5.42M	-3.97M	-2.53M	-0.98M	-1.78M	-1.47M	-1.01M	-1.49M	-1.71M	-0.97M	-0.90M	-9.03M	-2.22M	-2.62M
Additional items
EPS (Basic) (Quarter)	-0.00M	-0.00M	-0.00M	-0.00M	-0.01M	-0.01M	-0.00M	-0.00M	-971.30	-431.70	-609.56	-440.14	-142.34	-278.21	-184.93	-82.01	-22.30	-93.17	-4.18	-4.93
EPS (Diluted) (Quarter)	-0.00M	-0.00M	-0.00M	-0.00M	-0.01M	-0.01M	-0.00M	-0.00M	-971.30	-431.70	-609.56	-440.14	-142.34	-278.21	-184.93	-82.01	-22.30	-93.17	-4.18	-4.93
Shares Outstanding (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.01M	0.01M	0.01M	0.01M	0.04M	0.10M	0.53M	0.53M
Shares Outstanding (Diluted) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.01M	0.01M	0.01M	0.01M	0.04M	0.10M	0.53M	0.53M
Shares Outstanding (Entity) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.01M	0.01M	0.01M	0.01M	0.04M	0.10M	0.53M	0.53M
EBITDA (Quarter)	-3.75M	-4.14M	-6.12M	-4.76M	-14.49M	-6.48M	-5.42M	-3.97M	-2.53M	-0.97M	-1.77M	-1.47M	-1.01M	-1.49M	-1.72M	-0.97M	-0.90M	-9.03M	-2.28M	-2.63M
Interest Expenses (Quarter)	0.27M					13.04M				0.01M	0.00M	797.00	0.01M	-0.00M	0.00M	0.00M			0.01M	-0.01M

Research Tools

Datasets

Plans

Developers

Decoy Therapeutics DCOY Income Statement (2014-2026)

Research Tools

Datasets

Plans

Developers

Decoy Therapeutics DCOY Income Statement (2014-2026)

Create an account

Sign In

Reset Password